Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis
about
Medical management of neurogenic bladder with oral therapySymptomatic management in multiple sclerosisSystematic review of therapy for neurogenic detrusor overactivityBladder dysfunction in multiple sclerosis.Caregiver burden among informal caregivers assisting people with multiple sclerosis.Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelinesRehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials.The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.Management of neurogenic bladder in patients with multiple sclerosis.Neurogenic lower urinary tract dysfunction: evaluation and management.The impact of disabilities on quality of life in people with multiple sclerosis.Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion.[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].Desmopressin accelerates the rate of urinary morphine excretion and attenuates withdrawal symptoms in rats.The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
P2860
Q26767313-88A685FD-0741-4147-83F4-C38F50CAA756Q26779897-96C890C7-240D-48F1-B8FC-DFE62A67FC7CQ35347758-1E12F690-C364-4982-99D4-EA1EC48F5B12Q37409485-1B693211-D5AB-4808-9DE8-A73F8B325509Q37442062-6AEF5A09-3BE7-463B-9D3E-E45206374A82Q37720749-4C60203B-65A4-4B4F-9536-A1A027B6CE93Q37768289-04CD2E7E-2312-4BC6-8C98-610119A2339AQ37928494-87905C24-FB95-47E1-A9FB-8B854B454180Q38034119-37594FF5-93D7-41D2-A93A-16E72C1EE9F3Q38113739-70754F51-06F0-4149-BCD6-9459786F5487Q38508246-9AB8EFD2-C756-44FE-AF8A-69D98C25FE13Q38794193-B03F6B68-38E9-4DA8-B2C4-F7382A0CD0DDQ38892831-F4F177A1-F65C-4B70-B454-3A17C5C6B6B9Q45372885-443A6217-8B9A-45C5-BB2B-93F8E08D3C3CQ48121488-ABE08BA0-2A21-492E-9FF5-E71A0606DFA3Q50100443-BFD672A2-1C08-4F1F-A060-0FCCADBCFCDAQ52301973-6251012A-6B0E-421E-8709-C23815882501Q55486735-53FFF378-8DCF-4452-90D4-5F22D9C93AA1
P2860
Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@ast
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@en
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@nl
type
label
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@ast
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@en
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@nl
prefLabel
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@ast
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@en
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@nl
P2093
P1476
Efficacy of desmopressin in pa ...... r dysfunction: a meta-analysis
@en
P2093
P2860
P356
10.1111/J.1600-0404.2005.00431.X
P407
P577
2005-07-01T00:00:00Z